MedTrace Logo

Grass Observational Study

NCT02075138 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2015-04-08

No results posted yet for this study

Summary

Grass pollen allergens are universally recognised as a major cause of allergic diseases in humans, including asthma, allergic rhinitis, conjunctivitis and dermatitis.

The purpose of the current study is to evaluate allergy symptoms and allergy medication in subjects with grass-related rhinoconjunctivitis.

Conditions

  • Grass Allergy
  • Rhinoconjunctivitis

Sponsors & Collaborators

  • Syneos Health

    collaborator OTHER

  • CIDAL

    collaborator UNKNOWN

  • Circassia Limited

    lead INDUSTRY

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States
  • Argentina
  • Chile

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02075138 on ClinicalTrials.gov